منابع مشابه
Onychomycosis in patients with nail psoriasis
Onychomycosis is a nail infection caused by dermatophyte and non-dermatophyte molds and yeasts. The nail involvement is a feature of psoriasis, although skin manifestations are the most principal findings in psoriasis. Onychomycosis and psoriasis are both common disorders in communities. It is possible that in some patients these two diseases are present at the same time. A review was performed...
متن کاملNail psoriasis.
Nail psoriasis affects nearly 80% of patients with plaque psoriasis and is even more prevalent in patients with psoriatic arthritis. Nail psoriasis is not simply a cosmetic problem but one that effects the structure and function of the nail, resulting in negative psychological effects. The first level in management of nail psoriasis is patient education. The hierarchy of nail psoriasis therapy ...
متن کاملWeekend Ciclosporin Maintenance Therapy for Moderate Psoriasis.
Please cite this article as: Feltes F, Macías del Toro E, Ramírez Bellver JL, Bernardez Guerra C. Terapia de mantenimiento con ciclosporina en pauta de fin de semana para psoriasis moderada. Actas Dermosifiliogr. 2015;106:583--584. ∗ Corresponding author. E-mail address: [email protected] (F. Feltes). The use of ciclosporin microemulsion in a weekend regimen has been proposed as an alterna...
متن کاملTopical Therapies in Psoriasis
Topical therapy as monotherapy is useful in psoriasis patients with mild disease. Topical agents are also used as adjuvant for moderate-to-severe disease who are being concurrently treated with either ultraviolet light or systemic medications. Emollients are useful adjuncts to the treatment of psoriasis. Use of older topical agents such as anthralin and coal tar has declined over the years. How...
متن کاملCiclosporin in psoriasis clinical practice: an international consensus statement.
The main recommendations for the use of ciclosporin in the management of psoriasis are: (i) intermittent short courses (average of 12 weeks duration) of ciclosporin are preferable; (ii) ciclosporin should be given in the dose range 2.5-5.0 mg kg(-1) day(-1) (doses greater than 5.0 mg kg(-1) day(-1) should only be given in exceptional circumstances); (iii) treatment regimens should be tailored t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Dermatology
سال: 1990
ISSN: 1018-8665,1421-9832
DOI: 10.1159/000248005